| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI115393 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC295478 |
| https://europepmc.org/articles/PMC295478?pdf=render | ||
| P932 | PMC publication ID | 295478 |
| P698 | PubMed publication ID | 1832175 |
| P2093 | author name string | M. A. Reidy | |
| M. W. Majesky | |||
| S. M. Schwartz | |||
| D. R. Twardzik | |||
| V. Lindner | |||
| P2860 | cites work | A new type of transforming growth factor-beta, TGF-beta 3 | Q24564095 |
| Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor) | Q24634292 | ||
| Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene | Q28776291 | ||
| Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells | Q30461802 | ||
| Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability | Q33553280 | ||
| Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells | Q33557153 | ||
| Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation | Q33557263 | ||
| Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall | Q33567932 | ||
| An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes | Q33862469 | ||
| Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries | Q34254075 | ||
| Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery | Q34316431 | ||
| Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells | Q34333889 | ||
| Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization | Q34563319 | ||
| Growth factor expression in aorta of normotensive and hypertensive rats | Q34571323 | ||
| Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells | Q34630317 | ||
| Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels | Q68862060 | ||
| Heparin regulates smooth muscle S phase entry in the injured rat carotid artery | Q69206458 | ||
| Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells | Q69747770 | ||
| Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes | Q69890347 | ||
| Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro | Q70404833 | ||
| Three different fibronectin mRNAs arise by alternative splicing within the coding region | Q34708457 | ||
| Complementary DNA cloning of the murine transforming growth factor-beta 3 (TGF beta 3) precursor and the comparative expression of TGF beta 3 and TGF beta 1 messenger RNA in murine embryos and adult tissues | Q35749907 | ||
| Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells | Q35811776 | ||
| The aortic intima. II. Repair of the aortic lining after mechanical denudation | Q36077512 | ||
| Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells | Q36214722 | ||
| Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta | Q36218283 | ||
| Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice | Q36220077 | ||
| Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes | Q36220190 | ||
| Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture | Q36220333 | ||
| Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin | Q36222838 | ||
| Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta | Q36223233 | ||
| Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos | Q36223421 | ||
| PDGF ligand and receptor gene expression during repair of arterial injury | Q36223935 | ||
| Experimental arteriosclerosis. I. Fibrous plaque formation in primates, an electron microscope study | Q36272015 | ||
| Inhibition of protein synthesis stabilizes histone mRNA | Q36948561 | ||
| Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury | Q37401242 | ||
| Replication of smooth muscle cells in vascular disease | Q39731571 | ||
| A reassessment of endothelial injury and arterial lesion formation. | Q39832705 | ||
| Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to th endothelium | Q39974128 | ||
| Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells | Q40671327 | ||
| Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures | Q41541840 | ||
| Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner | Q41544649 | ||
| Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury | Q41826002 | ||
| A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. | Q42814129 | ||
| Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence | Q43463918 | ||
| Complete nucleotide sequence of the N-terminal domains of the murine alpha-1 type-III collagen chain | Q43527888 | ||
| Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix | Q43755354 | ||
| Endothelial cell behavior after denudation injury is modulated by transforming growth factor-beta1 and fibronectin. | Q44091735 | ||
| Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. | Q44804218 | ||
| Human transforming growth factor beta.alpha 2-macroglobulin complex is a latent form of transforming growth factor beta | Q44836846 | ||
| Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping | Q46070830 | ||
| Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells | Q46438394 | ||
| Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. | Q47180254 | ||
| Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization | Q47181164 | ||
| cDNA cloning of porcine transforming growth factor-beta 1 mRNAs. Evidence for alternate splicing and polyadenylation. | Q48309411 | ||
| Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. | Q50927284 | ||
| Arterial repair and atherosclerosis after mechanical injury. 2. Tissue response after induction of a total local necrosis deep longitudinal injury. | Q54644807 | ||
| Developmentally regulated production of platelet-derived growth factor-like molecules | Q59066829 | ||
| Intimal injury and regrowth in the rabbit aorta; medial smooth muscle cells as a source of neointima | Q66912811 | ||
| Alpha 1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta | Q67653123 | ||
| Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery | Q68339861 | ||
| TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop | Q68482825 | ||
| Fibronectin-associated transforming growth factor | Q68820998 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 904-910 | |
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Production of transforming growth factor beta 1 during repair of arterial injury | |
| P478 | volume | 88 |
| Q50576755 | A DNA enzyme targeting Egr-1 inhibits rat vascular smooth muscle cell proliferation by down-regulation of cyclin D1 and TGF-beta1. |
| Q80592795 | A novel polymorphism of the gene encoding furin, a TGF-beta1 activator, and the influence on cardiac allograft vasculopathy formation |
| Q46189301 | A pyrrole-imidazole polyamide targeting transforming growth factor-beta1 inhibits restenosis and preserves endothelialization in the injured artery |
| Q34089634 | A system for the direct co-culture of endothelium on smooth muscle cells |
| Q30470269 | A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements |
| Q34613526 | Accelerated reendothelialization, increased neovascularization and erythrocyte extravasation after arterial injury in BAMBI-/- mice |
| Q30464704 | Activated alpha 2-macroglobulin and transforming growth factor-beta 1 induce a synergistic smooth muscle cell proliferative response |
| Q35795094 | Active macrophage-associated TGF-beta co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries |
| Q34493509 | Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons |
| Q40670258 | Amphiregulin is a potent mitogen for the vascular smooth muscle cell line, A7r5. |
| Q35147533 | An agent-based model of the response to angioplasty and bare-metal stent deployment in an atherosclerotic blood vessel. |
| Q33718262 | Angiotensin II and connective tissue: homeostasis and reciprocal regulation |
| Q38314798 | Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells |
| Q34133039 | Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model |
| Q30756400 | Antisense oligonucleotides to c-fos and c-jun inhibit intimal thickening in a rat vein graft model |
| Q36681844 | Arterial ageing |
| Q35782312 | Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels |
| Q77338541 | Autoregulation of angiogenesis by cells of the vessel wall |
| Q78319598 | Biochemical analysis of collagen and elastin synthesis in the balloon injured rat carotid artery |
| Q30436661 | Biomechanical Regulation of Endothelium-dependent Events Critical for Adaptive Remodeling |
| Q37418743 | CD105 positive neovessels are prevalent in early stage carotid lesions, and correlate with the grade in more advanced carotid and coronary plaques |
| Q54789936 | CD8(+) T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination. |
| Q39769379 | CTRP3/cartducin is induced by transforming growth factor-beta1 and promotes vascular smooth muscle cell proliferation |
| Q30362674 | Calreticulin Regulates Neointima Formation and Collagen Deposition following Carotid Artery Ligation. |
| Q33633405 | Cardiovascular aging research: the next horizons |
| Q74412312 | Cellular and molecular mechanisms of radiation inhibition of restenosis. Part I: role of the macrophage and platelet-derived growth factor |
| Q34890522 | Central role of RAGE-dependent neointimal expansion in arterial restenosis |
| Q35764595 | Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease |
| Q60746676 | Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines |
| Q35767892 | Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. |
| Q74348126 | Differential expression of proteoglycans biglycan and decorin during neointima formation after stent implantation in normal and atherosclerotic rabbit aortas |
| Q36671684 | Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia |
| Q37679826 | Divergent signaling pathways cooperatively regulate TGFβ induction of cysteine-rich protein 2 in vascular smooth muscle cells |
| Q80592801 | Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease |
| Q41934611 | Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury |
| Q35945466 | Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease |
| Q73295912 | Dynamics of Vascular Remodeling: An Overview and Bibliography |
| Q35786318 | Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2 |
| Q43912985 | Effect of BO-653 and probucol on c-MYC and PDGF-A messenger RNA of the iliac artery after balloon denudation in cholesterol-fed rabbits. |
| Q41135997 | Effect of CTRP3 on activation of adventitial fibroblasts induced by TGF-β1 from rat aorta in vitro |
| Q36583492 | Effect of TGF-β1 on the Migration and Recruitment of Mesenchymal Stem Cells after Vascular Balloon Injury: Involvement of Matrix Metalloproteinase-14. |
| Q72820999 | Effect of endothelial cells and transforming growth factor-beta 1 on cultured vascular smooth muscle cell growth patterns |
| Q73409205 | Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques |
| Q37833506 | Endothelial Cell Vascular Smooth Muscle Cell Co-Culture Assay For High Throughput Screening Assays For Discovery of Anti-Angiogenesis Agents and Other Therapeutic Molecules |
| Q55066900 | Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. |
| Q37402084 | Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation |
| Q46976978 | Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment. |
| Q40512524 | Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system" |
| Q44264755 | Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment |
| Q37406279 | Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis. |
| Q37381419 | Evidence for a role of collagen synthesis in arterial smooth muscle cell migration |
| Q35607475 | Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions |
| Q54127845 | Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. |
| Q35801091 | Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response |
| Q46657594 | Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice |
| Q92555286 | Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development |
| Q35159977 | Gene profiling of the rat medial collateral ligament during early healing using microarray analysis |
| Q33939860 | High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. |
| Q24303697 | Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways |
| Q32048347 | Identification of multiple genes with altered expression at the distal anastomosis of healing polytetrafluoroethylene grafts |
| Q72934152 | Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation |
| Q44011679 | Increased transforming growth factor-beta(1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin |
| Q28534387 | Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder |
| Q77718662 | Inhibition of endothelial cell adhesion and proliferation by extracellular matrix from vascular smooth muscle cells: role of type V collagen |
| Q39795032 | Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. |
| Q35609149 | Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor |
| Q47987270 | Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries |
| Q34138108 | Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides |
| Q72257097 | Intimal hyperplasia producing thrombus organization in an experimental venous thrombosis model |
| Q38023144 | Intimal hyperplasia: slow but deadly |
| Q24311092 | Intracellular localization of Cthrc1 characterizes differentiated smooth muscle |
| Q47279584 | Intravascular ultrasound allows a hyperplasia diagnosis in vivo in rat as accurate as histomorphometry |
| Q73091580 | Lipoxygenase inhibition decreases neointimal formation following vascular injury |
| Q51687284 | Local Stent-Based Release of Transforming Growth Factor-β1 Limits Arterial In-Stent Restenosis. |
| Q36856174 | Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries |
| Q35832425 | Localization of Fos and Jun proteins in rat aortic smooth muscle cells after vascular injury. |
| Q70580275 | Localization of apolipoprotein(a) and B-100 in various renal diseases |
| Q38128321 | Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular Disease |
| Q47994394 | Low flow enhances platelet activation after acute experimental arterial injury |
| Q46294133 | Matrix proteins associated with bone calcification are present in human vascular smooth muscle cells grown in vitro |
| Q41740450 | Mechanisms of neointima formation--lessons from experimental models |
| Q41077850 | Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-beta1, with divergent effects of epidermal growth factor and tumor necrosis factor-alpha on collagen type I and collagen type IV. |
| Q33900223 | Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. |
| Q34364244 | Nanoparticle-mediated local delivery of an antisense TGF-β1 construct inhibits intimal hyperplasia in autogenous vein grafts in rats |
| Q30467899 | Native and activated forms of alpha 2-macroglobulin increase expression of platelet-derived growth factor alpha-receptor in vascular smooth muscle cells. Evidence for autocrine transforming growth factor-beta activity |
| Q41825577 | Neuropilins 1 and 2 mediate neointimal hyperplasia and re-endothelialization following arterial injury |
| Q35796028 | Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury |
| Q44556159 | Obstruction of St Jude Medical valves in the aortic position: histology and immunohistochemistry of pannus |
| Q33904134 | Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques |
| Q34544955 | Overcoming restenosis with sirolimus: from alphabet soup to clinical reality |
| Q37366599 | Overexpression of Prolyl-4-Hydroxylase-α1 Stabilizes but Increases Shear Stress-Induced Atherosclerotic Plaque in Apolipoprotein E-Deficient Mice. |
| Q36502796 | Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia |
| Q44452120 | Paracrine secretion of transforming growth factor-beta1 in aneurysm healing and stabilization with endovascular smooth muscle cell therapy |
| Q73140029 | Pathophysiologic significance of growth factors and new therapeutic concepts in cardiovascular disease |
| Q34719637 | Perspectives on mammalian cardiovascular aging: humans to molecules |
| Q40490671 | Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II). |
| Q36867909 | Photodynamic therapy inhibits transforming growth factor beta activity associated with vascular smooth muscle cell injury |
| Q73925017 | Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation |
| Q30305991 | Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. |
| Q41550281 | Processes in atherogenesis: complement activation |
| Q73643318 | Proliferation of intimal smooth muscle cells. Attenuation of basic fibroblast growth factor 2-stimulated proliferation is associated with increased expression of cell cycle inhibitors |
| Q44444364 | Protective Effect of the Immunosuppressant Sirolimus Against Aortic Atherosclerosis In Apo E-Deficient Mice |
| Q35763762 | Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta |
| Q36758114 | Rat mesangial cell hypertrophy in response to transforming growth factor-beta 1. |
| Q91955416 | Recipient c-Kit Lineage Cells Repopulate Smooth Muscle Cells of Transplant Arteriosclerosis in Mouse Models |
| Q37510851 | Redox control of the cell cycle in health and disease |
| Q35833909 | Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries |
| Q35652173 | Regulation of smooth muscle cell growth by endothelium-derived factors. |
| Q42411623 | Regulation of vascular smooth muscle cell growth: targeting the final common pathway |
| Q28273856 | Restricted expression of homeobox genes distinguishes fetal from adult human smooth muscle cells |
| Q42426414 | Role of TGF-β1/Smad3 signaling pathway in secretion of type I and III collagen by vascular smooth muscle cells of rats undergoing balloon injury |
| Q35763997 | Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries |
| Q36534829 | Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia |
| Q37041170 | Smooth muscle cell growth factors |
| Q34198618 | Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries |
| Q33955929 | Stainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosis |
| Q73840808 | Suramin inhibits proliferation of human arterial smooth muscle cells in vitro: potential drug for prevention of restenosis by local drug delivery |
| Q37339703 | TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. |
| Q30449271 | TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms |
| Q44319028 | TGF-beta stimulates collagen (I) in vascular smooth muscle cells via a short element in the proximal collagen promoter |
| Q40889047 | TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages |
| Q33857605 | TGF-betas and TGF-beta receptors in atherosclerosis |
| Q36042601 | TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells |
| Q34798852 | TGF-β and restenosis revisited: a Smad link |
| Q26824337 | TGF-β signaling via TAK1 pathway: role in kidney fibrosis |
| Q36468657 | TGF-β-activated kinase-1: New insights into the mechanism of TGF-β signaling and kidney disease |
| Q34007727 | TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A. |
| Q33898739 | TGF-β1/Smad signaling, MMP-14, and MSC markers in arterial injury: discovery of the molecular basis of restenosis |
| Q28712812 | TGFB1 genetic polymorphisms and coronary heart disease risk: a meta-analysis |
| Q37976673 | TGFβ signaling and cardiovascular diseases |
| Q60922525 | TGFβ, smooth muscle cells and coronary artery disease: a review |
| Q73530102 | Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells |
| Q39765351 | The alpha1beta1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization |
| Q28360490 | The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair |
| Q31072283 | The effect of TGF-beta receptor binding peptides on smooth muscle cells |
| Q77151290 | The extracellular matrix in balloon arterial injury: a novel target for restenosis prevention |
| Q24532213 | The latent transforming growth factor beta binding protein (LTBP) family |
| Q33890371 | The mechanisms of coronary restenosis: insights from experimental models |
| Q36437448 | The molecular basis of increased glomerulosclerosis after blockade of the renin angiotensin system in growth hormone transgenic mice |
| Q41150873 | The proliferation of neointimal smooth muscle cells cultured from rabbit aortic explants 15 weeks after de-endothelialization by a balloon catheter |
| Q36896406 | The role of the adventitia in vascular inflammation |
| Q47592128 | The role of the endoplasmic reticulum protein calreticulin in mediating TGF-β-stimulated extracellular matrix production in fibrotic disease |
| Q71850182 | The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression |
| Q34348104 | The use of micropatterning to control smooth muscle myosin heavy chain expression and limit the response to transforming growth factor β1 in vascular smooth muscle cells |
| Q35079607 | Therapeutic targets for treating fibrotic kidney diseases |
| Q30449306 | Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor |
| Q52181478 | Tissue-specific and developmental regulation of transforming growth factor-beta1 expression in fetal lamb ductus arteriosus endothelial cells. |
| Q42437922 | Transcriptional and post-transcriptional control of lysyl oxidase expression in vascular smooth muscle cells: effects of TGF-beta 1 and serum deprivation |
| Q41811073 | Transforming Growth Factor-β1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome. |
| Q35465343 | Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells |
| Q41233801 | Transforming growth factor beta in normal human lung: preferential location in bronchial epithelial cells. |
| Q36678525 | Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2 |
| Q74445982 | Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells |
| Q35043874 | Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation |
| Q46955907 | Transforming growth factor-beta 1 and ascorbate regulate proliferation of cultured smooth muscle cells by independent mechanisms |
| Q73177123 | Transforming growth factor-beta 1 increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells |
| Q35602630 | Transforming growth factor-beta 1 is decreased in remodeling hypertensive bovine pulmonary arteries |
| Q28364695 | Transforming growth factor-beta 1 stimulates vascular smooth muscle cell L-proline transport by inducing system A amino acid transporter 2 (SAT2) gene expression |
| Q35603155 | Transforming growth factor-beta in disease: the dark side of tissue repair |
| Q40345548 | Transforming growth factor-beta induction of smooth muscle cell phenotpye requires transcriptional and post-transcriptional control of serum response factor. |
| Q45931845 | Transforming growth factor-beta protein and messenger RNA expression is increased in the closing ductus arteriosus. |
| Q73295621 | Transforming growth factor-beta(1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells |
| Q37882523 | Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects |
| Q42014388 | Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways |
| Q71949871 | Transforming growth factor-β1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate—Dependent manner |
| Q39670808 | Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1. |
| Q28508850 | Tumor necrosis factor-alpha inhibits collagen alpha1(I) gene expression and wound healing in a murine model of cachexia |
| Q35833702 | Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions |
| Q35367492 | Tyrosine phosphorylation of platelet derived growth factor beta receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris |
| Q28076917 | Unique aspects of the developing lung circulation: structural development and regulation of vasomotor tone |
| Q34986363 | Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. |
| Q43955459 | Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats |
| Q35833446 | Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta |
| Q38532290 | Vascular smooth muscle cell-derived transforming growth factor-β promotes maturation of activated, neointima lesion-like macrophages |
| Q34253202 | Vascular smooth muscle cells ablation with endovascular nonthermal irreversible electroporation |
| Q35798565 | Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity |
| Q58614127 | Wound healing mechanism in Mongolian gerbil skin |
| Q34116215 | Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation |
| Q42812097 | YAP and TAZ regulate skin wound healing |
| Q53536509 | p55γ functional mimetic peptide N24 blocks vascular proliferative disorders. |
| Q71807379 | α v β 3 Integrin Expression in Normal and Atherosclerotic Artery |
Search more.